James Benedict Rowe

James Benedict Rowe serves as an Affiliate Professor in the Department of Clinical Medicine at the University of Cambridge's School of Clinical Medicine. His research focuses on neurodegenerative diseases, particularly frontotemporal dementia, Alzheimer's disease, and related neurological disorders. His work bridges clinical neurology, genetics, and neuroimaging to advance understanding of these complex conditions.

His research interests span multiple areas of neurological science, with primary emphasis on frontotemporal dementia, biomarker development, genetic factors in neurodegeneration, and neuroimaging techniques. His work has made significant contributions to understanding the genetic architecture of frontotemporal dementia and the development of diagnostic biomarkers for various neurodegenerative conditions. His research frequently involves large-scale international collaborations examining the genetic and physiological underpinnings of neurological disorders.

Analysis of his recent publications reveals a strong focus on the intersection of genetics and neuroimaging in neurodegenerative diseases. His work has contributed to identifying genetic risk factors for frontotemporal dementia, developing plasma biomarkers for differential diagnosis between neurodegenerative conditions, and understanding the neural mechanisms underlying cognitive deficits in these disorders. His research spans molecular genetics, neuroimaging, and clinical neurology, reflecting a comprehensive approach to understanding neurodegenerative diseases.

His publications have garnered significant attention, with one 2022 paper receiving 126 citations and being picked up by 11 news outlets. His work has been referenced in Wikipedia pages, clinical guidelines, and policy documents, demonstrating its impact on both scientific understanding and clinical practice.

Dr. Rowe participates in extensive international collaborations, working with researchers across Europe and North America. His research involves multiple consortia including The International ALS/FTD Genomics Consortium, The International FTD Genetics Consortium, and The International LBD Genomics Consortium, highlighting his role in large-scale collaborative neuroscience research.

He is actively involved with the European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND), contributing to advanced neuroimaging approaches for studying brain structure and function in neurodegenerative conditions.